hygene 100 iu

Hygene 100IU (Somatropin Human Growth Hormone) | NexorinPharma

Hygene 100IU is a recombinant Human Growth Hormone preparation containing 100 international units of Somatropin per kit. At NexorinPharma, we carry Hygene 100IU as part of our peptide and growth hormone inventory for customers in markets where Human Growth Hormone is legally available.

Somatropin is the active compound in Hygene 100IU. It is a synthetic form of Human Growth Hormone produced through recombinant DNA technology by Hygene Biopharm, the same manufacturer behind the widely referenced Hygetropin brand. The body produces Human Growth Hormone naturally through the anterior pituitary gland, driving growth, metabolism, body composition, and numerous other physiological processes. Hygene 100IU delivers a structurally identical version of that same hormone through injectable administration.

Like all growth hormone preparations, Hygene 100IU carries significant health and legal considerations. This page covers what Somatropin is, how it works, and what health and legal considerations apply. It does not constitute medical advice. It does not recommend or encourage hormone use. It does not provide dosage or cycle guidance of any kind.

Product Specifications

Website: nexorinpharma.com Product Name: Hygene 100IU Manufacturer: Hygene Biopharm Active Compound: Somatropin (recombinant Human Growth Hormone) Also Known As: HGH, rHGH, Human Growth Hormone, GH Drug Class: Peptide hormone, growth hormone Total Kit Content: 100IU per kit Presentation: Lyophilized powder for reconstitution Form: Injectable solution following reconstitution Half-Life: Approximately 2 to 3 hours following subcutaneous injection Route of Administration: Subcutaneous or intramuscular injection following reconstitution Molecular Structure: 191 amino acid sequence identical to endogenous Human Growth Hormone Manufacturer: Hygene Biopharm Legal Status: Prescription only in the United States and most developed countries. Legal status varies by country.

About Hygene Biopharm

Hygene Biopharm is a Chinese pharmaceutical manufacturer specializing in recombinant Human Growth Hormone preparations. The brand produces both the widely referenced Hygetropin single-vial format and the Hygene 100IU kit format for markets where Human Growth Hormone is legally available. Hygene Biopharm has maintained a consistent presence in international growth hormone markets for several years and carries recognition in bodybuilding and performance communities as one of the more consistently referenced non-prescription growth hormone manufacturers.

Like all growth hormone manufacturers operating outside major regulated pharmaceutical markets, Hygene Biopharm does not carry the manufacturing oversight, regulatory scrutiny, or clinical trial documentation of FDA-approved or EMA-approved pharmaceutical grade growth hormone products. Consequently, quality, purity, and concentration accuracy are less verifiable than with regulated products. Within the non-prescription growth hormone market, however, Hygene Biopharm is consistently referenced for product consistency and brand recognition across international performance communities.

About the 100IU Kit Format

The 100IU total kit content of Hygene represents a mid-range growth hormone preparation. Understanding the kit format is relevant context for anyone researching this specific product.

Kit Structure

Hygene 100IU is presented as a multi-vial kit containing multiple individual Somatropin vials that together total 100 international units. This kit format provides a larger total supply compared to standard single-vial preparations like Hygetropin 10IU. As a result, the 100IU kit format is a practical presentation for sustained growth hormone use over an extended period.

Comparison With Hygetropin Single-Vial Format

Hygetropin 10IU is the single-vial format produced by the same manufacturer, Hygene Biopharm. Hygene 100IU consequently provides the equivalent of 10 standard Hygetropin 10IU vials in a single kit presentation. Both preparations contain the same active Somatropin compound from the same manufacturer. The primary distinction between the two formats is the total supply quantity and kit presentation rather than any pharmacological difference in the active compound.

Non-Prescription Market Context

Hygene 100IU is produced for markets where Human Growth Hormone is legally available outside of prescription channels. It does not carry the manufacturing oversight, regulatory scrutiny, or clinical documentation of pharmaceutical grade FDA-approved Somatropin products. Quality, purity, and concentration accuracy are consequently less verifiable than with regulated products.

What Is Somatropin

The anterior pituitary gland produces Human Growth Hormone naturally, releasing it in pulses throughout the day. The largest pulse occurs during deep sleep. Human Growth Hormone is a peptide hormone consisting of a 191 amino acid single-chain polypeptide.

Somatropin is the recombinant form of that same hormone. Scientists produce it by inserting the human GH gene into bacterial or mammalian cell lines. Those cell lines then produce a 191 amino acid sequence structurally identical to the hormone the pituitary gland produces naturally. This recombinant production method replaced earlier cadaver-derived growth hormone preparations entirely and eliminated the serious health risks associated with those earlier methods.

Hygene 100IU contains Somatropin in lyophilized, or freeze-dried, powder form. Lyophilization preserves the peptide structure during storage. Before use, the powder requires reconstitution with bacteriostatic or sterile water.

How Somatropin Works

Somatropin works through two primary pathways. It acts directly on target tissues through growth hormone receptors and also stimulates IGF-1 production in the liver and other tissues, driving many of its downstream anabolic and metabolic effects.

Growth Hormone Receptor Activation

Somatropin binds to growth hormone receptors on target cells throughout the body. This binding activates intracellular signaling pathways that influence cell growth, differentiation, and metabolism. Growth hormone receptors are present in muscle tissue, adipose tissue, bone, the liver, and numerous other organs throughout the body.

IGF-1 Stimulation

Somatropin stimulates the liver to produce IGF-1, the primary mediator of Human Growth Hormone’s anabolic and growth-promoting effects. IGF-1 promotes cell growth, protein synthesis, and muscle tissue development. As a result, much of Somatropin’s anabolic activity is driven indirectly through IGF-1 rather than direct receptor activation alone.

Protein Synthesis

Somatropin increases protein synthesis throughout the body through both direct receptor activation and IGF-1 stimulation. Enhanced protein synthesis supports muscle tissue development, repair, and maintenance. Consequently, this is one of the most consistently referenced pharmacological characteristics of Human Growth Hormone in both clinical and performance community discussions.

Lipolysis

Somatropin stimulates lipolysis, the breakdown of stored fat in adipose tissue, by activating hormone-sensitive lipase in fat cells. This releases free fatty acids into circulation for use as energy. The lipolytic effect is therefore one of the most clinically documented metabolic actions of Human Growth Hormone and is directly relevant to its effects on body composition.

Bone Growth and Density

Somatropin stimulates bone growth and increases bone mineral density. In children and adolescents, it drives linear bone growth through chondrocyte proliferation in growth plates. In adults, on the other hand, it contributes to bone remodeling and density maintenance rather than linear growth.

Glucose Metabolism

Somatropin reduces insulin sensitivity and increases hepatic glucose production. These effects are dose-dependent and become clinically significant at concentrations above standard replacement therapy levels. For this reason, glucose metabolism is a primary metabolic health consideration with Somatropin use.

Fluid Retention

Somatropin increases sodium and water retention through its effects on the renin-angiotensin system. Fluid retention is one of the most commonly reported effects with growth hormone use and is dose-dependent in nature. In most cases, it resolves with dose reduction.

Why Hygene 100IU Is Referenced in Performance Communities

Human Growth Hormone generates consistent discussion in bodybuilding and performance communities. Several specific characteristics drive that discussion.

Body Composition Effects

Somatropin produces anabolic effects on muscle tissue through IGF-1 stimulation while simultaneously driving lipolysis in adipose tissue. This combined anabolic and fat-metabolizing profile distinguishes it from anabolic-androgenic steroids, which primarily drive anabolic activity without a direct lipolytic mechanism. As a result, Human Growth Hormone is a consistent topic in body composition discussions across performance communities.

Recovery and Tissue Repair

Human Growth Hormone plays a documented role in tissue repair and recovery. IGF-1 stimulation, enhanced protein synthesis, and collagen synthesis all contribute to the recovery-related observations discussed in performance communities. Furthermore, these mechanisms underpin its clinical applications in injury recovery and wound healing contexts.

Non-Androgenic Profile

Unlike anabolic-androgenic steroids, Somatropin does not bind to androgen receptors and does not produce androgenic side effects. Its side effect profile therefore differs fundamentally from anabolic steroids. This non-androgenic characteristic drives discussion among individuals seeking anabolic effects without the androgenic side effect considerations associated with anabolic steroid use.

Hygene Biopharm Brand Recognition

Hygene Biopharm carries consistent recognition in international performance communities through both the Hygetropin single-vial format and the Hygene 100IU kit format. This brand recognition contributes to the consistent discussion of Hygene products in performance communities as one of the more referenced non-prescription growth hormone manufacturers available.

100IU Kit Convenience

The 100IU kit format provides a practical total supply for sustained growth hormone use without the need to source multiple individual single-vial preparations. This convenience factor drives discussion of kit formats like Hygene 100IU in performance communities where extended administration periods are commonly referenced.

Clinical Background

Somatropin carries a well-documented clinical history across multiple FDA-approved indications. This background sets it apart from most compounds discussed in performance communities.

Growth Hormone Deficiency in Children

The FDA approves Somatropin for growth failure in children with inadequate endogenous growth hormone secretion. Clinical trials document consistent improvements in linear growth velocity in growth hormone-deficient children. This represents the most historically established clinical indication for Human Growth Hormone therapy.

Growth Hormone Deficiency in Adults

The FDA also approves Somatropin for adult growth hormone deficiency. Adults with documented deficiency experience improvements in body composition, bone density, lipid profiles, and quality of life with replacement therapy under medical supervision.

HIV-Associated Wasting

In addition, the FDA approved Somatropin for HIV-associated wasting and cachexia under the brand name Serostim. Clinical trials document improvements in lean body mass and physical performance in HIV-positive patients with wasting. This approval reflects its documented efficacy in muscle mass preservation under catabolic conditions.

Short Stature Conditions

The FDA approves Somatropin for several short stature conditions including Turner syndrome, Noonan syndrome, Prader-Willi syndrome, and short stature homeobox gene deficiency. These pediatric indications reflect the breadth of its clinical applications across growth-related conditions.

Short Bowel Syndrome

The FDA also approved Somatropin under the brand name Zorbtive for short bowel syndrome in patients dependent on parenteral nutrition. This represents a distinct clinical application entirely outside of growth and body composition indications.

Hygene 100IU Versus Other Growth Hormone Preparations

Versus Hygetropin 10IU

Hygetropin 10IU is the single-vial format produced by the same Hygene Biopharm manufacturer. Both preparations contain identical Somatropin produced through the same recombinant manufacturing process. The Hygene 100IU kit consequently provides 10 times the total supply of a single Hygetropin 10IU vial in a single kit presentation. The active compound, pharmacological profile, and risk profile are identical between the two formats.

Versus Hutrope 100IU

Hutrope 100IU provides the same total 100IU content as Hygene 100IU. Both are non-prescription 100IU kit format growth hormone preparations. The primary distinction is the manufacturer rather than the total supply or pharmacological profile of the active compound. Both carry the same general considerations applicable to non-prescription Somatropin preparations produced outside regulated pharmaceutical frameworks.

Versus Gentropin 210IU

Gentropin 210IU provides a larger total supply of 210 international units compared to Hygene 100IU’s 100 international units. Both are non-prescription growth hormone kit preparations from different manufacturers. Hygene 100IU consequently represents a more compact total supply format than Gentropin 210IU while providing a more substantial supply than standard single-vial formats.

Versus Pharmaceutical Grade Somatropin

FDA-approved Somatropin products including Genotropin, Humatrope, Norditropin, Nutropin, and Saizen carry strict regulatory oversight, comprehensive batch testing, and verified concentration accuracy. Hygene 100IU is produced outside these regulatory frameworks. Quality verification standards consequently differ fundamentally between pharmaceutical grade and non-prescription growth hormone preparations regardless of the total supply format.

Reconstitution and Storage

Hygene 100IU is supplied as a lyophilized powder and requires reconstitution before use. Proper handling is essential for maintaining peptide integrity throughout the process.

Reconstitution

Use bacteriostatic water or sterile water for injection. Bacteriostatic water is preferred for multi-dose vials as it contains a preservative that inhibits bacterial growth. Inject the water slowly along the inside wall of the vial rather than directly onto the powder. Then gently swirl the vial to mix. Shaking the vial degrades the peptide structure and must be avoided.

Storage Before Reconstitution

Store lyophilized powder refrigerated between 2 and 8 degrees Celsius, away from direct light and heat. Properly stored powder maintains stability for the duration of its labeled shelf life.

Storage After Reconstitution

Store reconstituted solution refrigerated between 2 and 8 degrees Celsius. Reconstituted solution is significantly less stable than lyophilized powder, so use it within the recommended timeframe. Freezing reconstituted solution degrades the peptide structure and must be avoided entirely.

Side Effects and Health Risks

Hygene 100IU carries a well-documented side effect profile based on extensive clinical research across Somatropin’s approved indications.

Fluid Retention and Edema

Fluid retention is one of the most commonly reported effects with Somatropin use. It produces swelling in the extremities, joint discomfort, and carpal tunnel symptoms. These effects are dose-dependent and generally resolve with dose reduction.

Carpal Tunnel Syndrome

Numbness, tingling, and pain in the hands and wrists are consistently reported in both clinical research and performance community discussions about growth hormone use. Fluid retention and tissue swelling in the wrist compress the median nerve, producing these symptoms. This side effect is therefore relevant to anyone using growth hormone preparations regardless of concentration.

Insulin Resistance

Somatropin reduces insulin sensitivity and increases hepatic glucose production in a dose-dependent manner. At concentrations above standard clinical replacement levels, insulin resistance becomes a significant health concern. Consequently, monitoring fasting glucose and insulin sensitivity is an important consideration for anyone using Somatropin.

Joint and Muscle Pain

Joint pain, muscle pain, and musculoskeletal discomfort are commonly reported with Somatropin use. These effects are associated with fluid retention and tissue growth and are generally dose-dependent. In most cases, they reduce with lower concentrations.

Acromegaly Risk

Long-term supraphysiological Somatropin use carries documented acromegaly risk. Acromegaly produces excessive growth of bone and soft tissue, resulting in enlargement of the hands, feet, and facial features. It carries serious long-term consequences including cardiovascular complications and joint disease. This risk is therefore directly relevant to anyone using growth hormone at concentrations exceeding physiological replacement levels over extended periods.

Cancer Risk Considerations

Human Growth Hormone stimulates cell growth and proliferation throughout the body. Clinical guidelines consequently caution against Somatropin use in individuals with active malignancy. The relationship between long-term supraphysiological growth hormone exposure and cancer risk remains an area of ongoing research. Anyone with a personal or family history of malignancy should therefore discuss this consideration with their physician before using any growth hormone preparation.

Pituitary Suppression

Exogenous Somatropin suppresses the pituitary gland’s natural growth hormone secretion through negative feedback on the hypothalamic-pituitary axis. Long-term use consequently reduces natural growth hormone output. The extent and reversibility of this suppression varies depending on duration and concentration of use.

Injection Site Reactions

Subcutaneous injections carry risks including localized pain, redness, swelling, and lipoatrophy with repeated injection at the same site. Rotating injection sites reduces these risks significantly.

Legal and Regulatory Status

Somatropin is prescription-only in the United States and most developed countries. The FDA approves it for specific clinical indications under multiple brand names. Outside of these indications, obtaining it without a valid prescription is a legal offense in many jurisdictions.

In the United States, Human Growth Hormone carries additional legal restrictions beyond standard prescription requirements. Federal law specifically prohibits its distribution for anti-aging, athletic performance, or bodybuilding purposes regardless of prescription status. This legal distinction is directly relevant to anyone researching Hygene 100IU in a US context.

The World Anti-Doping Agency bans Somatropin and all growth hormone preparations in competitive sports. As a result, it appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of Somatropin in your specific jurisdiction before purchasing from NexorinPharma.

Frequently Asked Questions

Is Hygene 100IU Available at NexorinPharma

Yes. NexorinPharma carries Hygene 100IU for customers in markets where Human Growth Hormone is legally available. Visit nexorinpharma.com to check current availability and pricing.

What Is the Total Content of Hygene 100IU

The Hygene 100IU kit contains a total of 100 international units of Somatropin. This is equivalent to 10 standard Hygetropin 10IU single-vial growth hormone preparations from the same Hygene Biopharm manufacturer.

How Does Hygene 100IU Differ From Hygetropin 10IU

Both preparations contain the same Somatropin active compound produced by Hygene Biopharm through the same recombinant manufacturing process. The distinction is the total supply format. Hygene 100IU provides 100 international units in a kit format while Hygetropin 10IU provides 10 international units per individual vial. The pharmacological profile and risk profile are consequently identical between the two formats.

What Is the Half-Life of Somatropin

Somatropin produces a half-life of approximately 2 to 3 hours following subcutaneous injection. Despite this short half-life, biological effects persist significantly longer through IGF-1 stimulation and downstream receptor-mediated signaling.

How Is Hygene 100IU Reconstituted

Use bacteriostatic water or sterile water for injection. Inject slowly along the inside wall of the vial, then gently swirl to mix rather than shaking. Store reconstituted solution refrigerated and use it within the recommended timeframe.

Does Somatropin Cause Insulin Resistance

Yes. Somatropin reduces insulin sensitivity and increases hepatic glucose production in a dose-dependent manner. Regular monitoring of fasting glucose and insulin sensitivity is therefore relevant for anyone using this compound.

What Are the Most Serious Health Risks

Acromegaly from long-term supraphysiological use, insulin resistance, cancer risk considerations, and pituitary suppression are the most serious long-term concerns. Fluid retention, carpal tunnel syndrome, and joint pain are the most commonly reported immediate side effects. Medical supervision is therefore essential for anyone using growth hormone preparations.

Is Hygene 100IU Legal to Purchase

Somatropin is prescription-only in the United States and most developed countries. US federal law specifically prohibits its distribution for anti-aging, athletic performance, or bodybuilding purposes. You are responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.

What to Consider Before Purchasing Hygene 100IU

Somatropin has a broader clinical research base than most compounds discussed in performance communities. Its multiple FDA-approved indications and decades of clinical trial data provide a substantial body of safety and pharmacology research. That research base applies to the pharmacological and risk profile of the active compound regardless of the specific manufacturer or format.

The Hygene Biopharm non-prescription format does not carry the manufacturing oversight of pharmaceutical grade Somatropin products. Furthermore, side effects documented in clinical research at approved therapeutic doses become more relevant at higher concentrations used outside of clinical supervision. The 100IU kit format reflects a meaningful total supply relevant to extended administration periods, making the cumulative health considerations associated with long-term Somatropin use particularly relevant to this product.

Somatropin carries documented risks including insulin resistance, acromegaly, pituitary suppression, fluid retention, and cancer risk considerations. Medical supervision is therefore essential for managing these risks responsibly. Consult a licensed medical professional before use.

For customers in markets where Human Growth Hormone is legally available, visit nexorinpharma.com to check current Hygene 100IU availability, pricing, and stock levels.